1. Introduction
Leishmaniases are endemic diseases that are widespread in regions such as Asia, Europe, Africa, and the Americas. Due to the fact that they are difficult to control, their capacity to cause epidemics, and their ability to cause fatalities and deformities, these diseases are important public health problems [1]. Among the 53 Leishmania species reported, only 20 can cause human infection [2]. Parasite transmission occurs in a vector-host cycle through blood repast of female phlebotomines in the Lutzomyia or Phlebotomus genus in a vertebrate host [3]. In a vertebrate host, the parasites are phagocytosed by macrophages and differentiate into amastigotes that, after intense multiplication by binary fission, rupture the cells and immediately infect new cells [4]. The appearance of ulcers may occur after the second week of infection [5,6], and after this initial lesion, the progression of the disease depends on several factors, including the Leishmania species and the patient’s immune system status. There are traditionally four clinical presentations of the disease: cutaneous leishmaniasis, cutaneous-diffuse leishmaniasis, cutaneous-mucosal leishmaniasis, and visceral leishmaniasis [1].
The biological cycles of different Leishmania spp. are strongly driven by nuances in their metabolic profiles that are related to the composition of their specific degradomes, including the protease and its respective substrate repertoire [7]. Their enzyme class (EC) is hydrolases (3) subclassified as peptidases (3.4) according to their physicochemical, biochemical, and structural features. Based on the method of peptide bond cleavage, there are two groups of serine proteinases: exopeptidases (EC 3.4.11-19) that cleave peptide bonds at the ends of a polypeptide, and endopeptidases or proteinases (EC 3.4.21-99), which cleave internal peptide bonds within the polypeptide chain and are named based on the amino acids that form the catalytic site, e.g., aspartic proteinases, cysteine proteinases, metalloproteinases, serine proteinases, threonine proteinases, and glutamic proteinases [8].
Aspartic proteinases, cysteine proteinases, metalloproteinases, and serine proteinases whose actions ensure the survival, proliferation, and maintenance of the Leishmania spp. life cycle in the host have been described. These enzymes act as virulence factors implicated in tissue invasion, survival of Leishmania sp. in macrophages, and modulation of immune response, driving specific clinical manifestations in the mammalian host [9,10]. Specifically, Leishmania (Viannia) braziliensis proteinase genes represent 2.18% of the parasite’s genome. In this parasite, metalloproteinase genes predominate the parasitic protease genes (14 families distributed in 7 clans), followed by cysteine proteinases (11 families distributed in 3 clans), and serine proteinases (10 families distributed in 8 clans). Aspartic proteinases are present in lower abundance in this parasitic genome (2 families distributed in 2 clans) [11].
Of the 17 predicted biological functions related to Leishmania sp. serine proteinase genes, only 18% were related to parasite physiology, including their activity as signal peptidases for removing the signal peptide from secretory preproteins, as maturases of other proteins, and as metacaspases [7]. The 26 to 28 serine proteinase genes from Leishmania sp. are classified in 10 families (S8, S9, S10, S12, S15, S16, S26, S51, S54 and S59) and grouped into 8 clans (SB, SC, SE, SF, SJ. SP, ST and PC) [7,12]. Unlike metalloproteinases and cysteine proteinases, whose biologic activities have been proven in the life cycle of L. (V.) braziliensis, serine proteinases have not been properly studied in this parasite [13].
Serine proteinases interact in a network of other proteases, proteins, and/or enzymes in the parasite [7]. As an example, subtilisin is a maturase of tryparedoxin peroxidase (TXNPx), an enzyme involved in the survival of the parasite inside macrophages, which plays a role in the detoxification system, namely trypanothione reductase system [14]. There are subtilisin genes in chromosomes 13 and 28 in Leishmania spp. However, only the genes LinJ13_V3.0940 and LmjF13.1040 have been related with this function [14]. Since these genes are orthologous to serine proteinases in L.(V.) braziliensis, it is possible that the Lbrm.13.0860 gene has the same function, but this has not yet been confirmed for the gene in chromosome 28.
This work aimed to study serine proteinases of L. (V.) braziliensis, including subtilisin-like proteinases (Family S8, Clan SB). The genome of this parasite contains two subtilisin genes (LbrM.13.0860 and LbrM.28.2570) and one TXNPx gene (LbrM.15.1080). To date, the relationship between these genes and their respective gene products in L. (V.) braziliensis has not been adequately described. The present study contributes to knowledge on the subcellular distribution of serine proteinases and the expression of two subtilisins in this parasite.
2. Results 2.1. Detection of Serine Proteinases in Subcellular Fractions of Promastigotes
In the first step of this study, the subcellular locations of serine proteinase of L. (V.) braziliensis were assessed. These assays were performed with serine proteinase-enriched fractions (membrane fraction and cytosolic fraction), obtained by affinity chromatography that were analyzed by using gelatin-SDS-PAGE, fluorogenic peptide substrates, and specific inhibitors.
Both the membrane and cytosolic fractions were obtained from 108 promastigotes/mL yielding approximately 0.6 ± 0.02 mg/mL protein, which showed a gelatin-SDS-PAGE profile with major proteinase bands with estimated molecular masses of 43 kDa, 48 kDa, 63 kDa, 99 kDa, and 170 kDa in the cytosolic fraction and 67 kDa, 75 kDa, and 170 kDa in the membrane fraction (Figure 1 inset).
The specific substrates Z-FR-AMC and Suc-AFK-AMC were used in enzymatic activity assays, and higher activities with these substrates were found in the cytosolic fraction (392 ± 30 µmol·min−1 mg of protein−1 and 252 ± 20 µmol·min−1 mg of protein−1, respectively) than in the membrane fraction (53 ± 5 µmol·min−1 mg of protein−1 and 63 ± 6 µmol·min−1·mg of protein−1, respectively, see Figure 1). The specificity was confirmed by inhibition assays in the presence of selective inhibitors. The proteinase activity against Z-FR-AMC and Suc-AFK-AMC was more strongly inhibited by aprotinin in the cytosolic fraction (77% and 44%, respectively) than in the membrane fraction (39% and 19%, respectively). PMSF also inhibited the activity against Z-FR-AMC in the cytosolic (63%) and membrane (69%) fractions but not against Suc-AFK-AMC in the membrane and cytosolic fractions (approximately 3%). Interestingly, E-64 only inhibited the enzymatic activity in the cytosolic fraction when Z-FR-AMC was the substrate (61%, see Figure 1).
2.2. Gene Transcripts Detected in Promastigotes
In the second step of this study, the expression of L. (V.) braziliensis LbrM.13.0860 and LbrM.28.2570 genes was investigated. As expected, the designed primers were specific for the conserved region of the L. (V.) braziliensis subtilisin gene and were used to amplify a 200 bp fragment of LbrM.13.0860 and a 162 bp fragment of LbrM.28.2570 from cDNA samples by PCR (Figure 2). The 98 bp 40S ribosomal protein S8 gene (LbrM.24.2160) was included in this study as a constitutive gene expression control. The intensity of the bands for the PCR products indicated more LbrM.13.0860 than LbrM.28.2570 transcripts in the promastigote cDNA samples. Additionally, LbrM.15.1080 transcripts were also observed in promastigotes in the stationary phase, which yielded a 166 pb PCR product.
2.3. Prediction of Subtilisin Subcellular Localization
In the third step of this study, an in silico analysis was performed to predict the location of L. (V.) braziliensis subtilisins (LbrM.13.0860 and LbrM.28.2570), based on their protein structures (Figure 3 and Figure 4). Calculations were performed using the PredictProtein server and indicated that both proteins differ in their secondary structure content as follows: LbrM.13.0860 [β-strand (9.9%), α-helix (15.7%) and loop (74.4%)] and LbrM.28.2570 [β-strand (10.7%), α-helix (26.5%), and loop (62.8%)], (Figure 3).
Differences were also observed in the prediction of the subcellular localizations of these proteins, which was based only on sequence properties by using a deep neural network provided by the DeepLoc-1 server. The accuracy of these analyses was assessed with three L. (V.) braziliensis proteins (two with RNA binding capacity (LbrM.25.2210 and LbrM.30.3080) [15], and dipeptidyl-peptidase 3 (LbrM.05.0940) [16], all of which have experimentally defined subcellular locations. The program accurately identified the cellular location of LbrM.25.2210 as the parasite nucleus (0.50) and LbrM.30.3080 and LbrM.05.0940 as the cytoplasm (0.85 and 0.97, respectively, data not shown). After confirming the accuracy of the analysis, the proteins from the LbrM.13.0860 and LbrM.28.2580 genes were predicted to be cytoplasmic (0.24) and membranous (0.85), respectively (Figure 4A).
Data gathered using the Protter server showed that LbrM.13.0860 (Figure 4B) contains mostly free sequences between amino acids 1735 and 1753, which indicate its localization within an organelle or in the cytoplasm. In contrast, the LbrM.28.2570 protein contains transmembrane regions along its entire sequence and is most likely present on the membrane of an organelle or on the surface membrane of the parasite. The conformation of the predicted protein identified amino acid residues with N-type glycosylation in LbrM.13.0860 (n = 16) and LbrM.28.2570 (n = 15). In addition, a signal peptide sequence was identified in the N-terminal portion (1 to 38 amino acids) of the LbrM.13.0860 protein (Figure 4B).
3. Discussion
Serine proteinases from Leishmania (V.) braziliensis promastigotes are poorly understood, especially regarding their roles in the adaptation to the environment within an invertebrate host, and biochemical studies related to these enzymes could improve our understanding of this parasite physiology. These enzymes are believed to act in a network of proteins that catalyze the cleavage of peptide bonds to maintain the physiological equilibrium of this parasite [7]. Therefore, studies to identify these enzymes in promastigotes are necessary for understanding the mechanism used by parasites for their adaptation to insect environments. In the present study, it was proposed that serine proteinases are found in the cytoplasm and membrane of L. (V.) braziliensis promastigotes, which are parasites responsible for most tegumentary leishmaniasis cases in Latin America [17].
To determine the location of proteinases in L. (V.) braziliensis promastigotes, a successful approach involving the fractionation of cellular compartments was applied here. In a broader analysis, subcellular fractions obtained from promastigotes in the stationary phase of growth exhibited serine proteinase activity demonstrated by the hydrolysis of gelatin and were distributed in the cellular compartments of the parasite, such as the cytosol (43 kDa to 170 kDa) and membrane (67 kDa to 170 kDa). Specific enzyme assays confirmed that protein preparations obtained by affinity chromatography contained serine proteinases, due to their ability to cleave highly specific fluorogenic substrates such as Z-FR-AMC, a substrate of cathepsins, kallikrein, and plasmin [18], and Suc-AFK-AMC, a substrate of plasmin [19], both of which contain positively charged residues at the P1 position.
Furthermore, molecular masses found in both fractions agree with previous findings regarding the serine proteinases in L. (V.) braziliensis promastigote, which have been described as exhibiting a broad range of molecular weights from 30 kDa to 130 kDa with gelatinolytic activity [20,21]. Nevertheless, it is important to comment that the applied methodology in these two previous studies differs from the strategy used in the present work, which can explain some differences in the serine proteinase profile detected here. In fact, the combination of subcellular fractioning and benzamidine-agarose chromatography was favorable for finding serine proteinase bands not previously detected using detergent fractioning [20] and freeze-thawing, differential centrifugation, and aprotinin-agarose chromatography [21]. In addition, the enzyme profile obtained in this work showed a broader range of molecular masses that is different from the subtilisin profile described for Bacillus subtilis, which included molecular masses from 20 kDa to 45 kDa [22,23,24]. However, it is necessary to highlight that the higher molecular masses detected here by gelatinolytic activities are close to the predicted molecular masses for LbrM.13.0860 (~190.8 kDa) in the cytosolic fraction and as LbrM.28.2570 (~188.2 kDa) in the membranous fraction. In addition, this is the first study to report the serine proteinase profile of L. (V.) braziliensis promastigotes purified based on their affinity to benzamidine.
The analysis of the serine proteinase subcellular locations performed here was an important strategy, because a protein’s function, as well as its interactive networks, depends on the cellular location of each protein component in the respective network. Thus, during this work, it was opportune to perform the in silico characterization of L. (V) braziliensis subtilisin cellular location. These analyses yielded interesting findings that need some explanation. We compared the performance of the DeepLoc-1 and Protter model prediction algorithms and found that both models significantly predicted the LbrM.13.0860 and LbrM.28.2570 as cytosolic and membrane proteins, respectively. Furthermore, it is important to emphasize that both methods are sequence-based methods that do not rely on annotation information from homologous proteins [25,26].
Since these algorithms indicated LbrM.28.2570 to be a membrane protein with intracellular and extracellular regions, the arrangement of the catalytic site of this enzyme requires additional comments. Comparative sequence analysis of LbrM.13.0860 and LbrM.28.2570 genes (Supplementary Material Figure S1) showed 16.1% sequence identity based on the catalytic site of LbrM.13.0860 gene in the S8 domain. While LbrM13.0860 gene has well-defined catalytic site residues (Aspartic Acid 97, Histidine 130, Asparagine 273 and Serine 339), the catalytic residues of the LbrM28.2570 gene have not yet been defined. However, by aligning the S8 domain of both genes, it was possible to find that LbrM13.0860 was aligned with the extracellular and intracellular regions of LbrM.28.2570, showing that both regions have the potential to form a catalytic site similar to described for LbrM13.0860 gene. Different quantities of these residues are distributed at different positions in the intracellular region [aspartic acid (n = 7), histidine (n = 3), asparagine (n = 7) and serine (n = 11)] and the extracellular region [aspartic acid (n = 12), histidine (n = 2), asparagine (n = 10) and serine (n = 15)].
The cellular locations of these enzymes in L. (V.) braziliensis agrees with the possible action of these enzymes in the parasite [7], since contact with the host and some metabolic pathways occurs at physiological pH. This can be explained by the catalytic site of serine proteinase, which is part of a charged network involving the amino acid residues in the catalytic triad. It is possible that this charged network can be activated by subtilisin from this protozoan in its environment, as proposed for bacterial subtilisin [27,28,29]. Since a charged network can influence the activity of promastigote serine proteinases in the spaces within the host’s body, the catalytic site in these enzymes must have an organization favorable for these activities. Thus, it is possible that the charged network containing the catalytic site of LbrM.28.2570 is dependent on the final fold of this protein, which in turn is dependent on the chemical environment in the different hosts of the parasite.
The results of the enzymatic activity in this work corroborated the predictive calculations of the subcellular localizations of the subtilisins in L. (V) braziliensis and are in agreement with one of the functions described for these enzymes, namely, processing TXNPx in amastigotes [30,31,32,33]. In addition, due to the presence of LbrM.15.1080 transcripts in promastigotes in the stationary growth phase in culture, and the fact that Leishmania (Leishmania) amazonensis promastigotes expressed TXNPx during their growth in culture [34], it is plausible that subtilisins can also act as maturases for promastigote proteins.
Additionally, an interesting finding of this work was the inhibition profile of E-64, an irreversible and selective inhibitor of cysteine proteinases that also inhibits serine proteinases, except for trypsin-like proteinases [35]. The inhibitory effect observed on the cytosolic fraction with Z-FR-AMC substrate suggested that some of the serine proteinases in the cytosol have a catalytic mechanism similar to that of cysteine proteinases. This finding can be explained by the similarity of the catalytic mechanisms of both proteinases, which are influenced by pH change driven by pH-sensing residues [36]. Another explanation for this finding is the possibility that benzamidine affinity chromatography retained cysteine proteinases from the protein preparations due to hydrogen bonding residues arranged without tension, and the formation of an oxyanion hole resembling the active site of a serine proteinase [37].
Finally, in this work, we described the transcription of genes for subtilisins in promastigotes by RT-PCR. Although these results suggested that both LbrM.13.0860 and LbrM.28.2570 gene transcripts are produced by stationary phase promastigotes under culture conditions, the specific PCR amplification product profiles detected on an agarose gel suggested a quantitative difference in the expression of both genes. It is likely that these genes may be expressed alternately during the culture timeline, but additional assays are required to prove this hypothesis.
4. Materials and Methods
Reagents—Detergents [Tween 20, Triton X-100 (TX-100), and 3-[(3-cholamidopropyl)-dimethylammonium]-1-propanesulfonate (CHAPS)], gelatin, bovine serum albumin (BSA), penicillin, proteinase inhibitors [trans-epoxysuccinyl-l-leucylamido(4-guanidino)butane (E-64), phenylmethanesulfonyl fluoride (PMSF) and aprotinin], fluorogenic peptide substrates [N-benzyloxycarbonyl-l-phenylalanyl-l-arginine 7-amino-4-methylcoumarin (Z-FR-AMC) and N-succinyl-l-alanine-l-phenylalanine-l-lysine 7-amino-4-methylcoumarin (Suc-AFK-AMC); ε= 1.78 × 104 M−1 cm−1], a ProteoSilver™ Silver Stain Kit, and Nancy-520 DNA gel stain were purchased from Sigma Aldrich Chemical Co. (St. Louis, MO, USA). A HiTrap® Benzamidine Fast Flow column (HiTrap Benzamidine; 1.5 × 2.5 cm) was purchased from GE Healthcare. Fetal calf serum (FCS) was purchased from Cultilab S/A (Campinas, SP, Brazil). The electrophoresis reagents were purchased from Bio-Rad Laboratories Inc. (Hercules, CA, USA). The full-range RainbowTM kit (12 to 225 kDa) was purchased from GE Healthcare Life’s Sciences (Little Chalfont, UK). Amicon Centriprep YM-10 filter devices were purchased from Millipore (Burlington, MA, USA). TRIzol® RNA Isolation Reagent (TRIzol), RNase Henzyme, DEPC-treated water, deoxyribonucleotide phosphate solution (dNTPs), a SuperScript III First-strand cDNA Synthesis Kit (SuperScript III kit), Platinum Taq DNA Polymerase (DNA Polymerase), and Taq Platinum PCR buffer were purchased from Invitrogen Life Technologies (Carlsbad, CA, USA). A RNeasy Mini Kit and RNase OUT enzymes were purchased from Qiagen (Hilden, Germany). A Wizard SV Gel Kit and PCR Clean-Up System were purchased from Promega Corporation (Madison, WI, USA). All other reagents were of analytical grade or better.
Parasite cultures—Leishmania (Viannia) braziliensis (MCAN/BR/1998/619) promastigotes were maintained at 28 °C in Schneider’s medium pH 7.2 (containing 1 mM l-glutamine, 10% FCS, 100 IU/mL penicillin, and 100 μg/mL streptomycin), with frequent sub passages to maintain the parasites in the logarithmic growth phase. Parasites from the stationary phase of growth after four days of culturing were used in subsequent experiments.
Subcellular fractionation—Subcellular fractions enriched with membrane and cytosolic proteins were obtained by centrifugal fractionation as previously described [38,39]. Briefly, promastigotes (108 cells/mL) were washed twice (3800× g, 4 °C, 10 min) in PBS pH 7·0, followed by two more wash cycles (3800× g, 4 °C, 10 min) in 10 mM Tris-HCl pH 7·2 buffer containing 1 M NaCl, 0·2 M K2HPO4, and 0·5 M MgCl2. The pellet (10 mL/g promastigotes) was then resuspended in 10 mM Tris-HCl, pH 7·5, containing 0·05 M sucrose, and disrupted in 1% CHAPS using a Dounce-type homogenizer with 0·25 M sucrose. After centrifugation (4300× g, 4 °C, 10 min), the resultant supernatant was centrifuged (12,000× g, 4 °C, 15 min), and the supernatant was centrifuged again (35,000× g, 4 °C, 45 min) to obtain a new pellet that contained the membrane fraction. The supernatant of the last centrifugation step was the cytosolic fraction.
Benzamidine affinity chromatography—Serine proteinase-enriched fractions were obtained from soluble subcellular protein preparations (30 mg/mL). The protein preparations were resuspended in buffer (10 mM Tris-HCl, pH 7.5, containing 1% CHAPS) and passed through a HiTrap Benzamidine column that had been previously equilibrated with binding buffer (0.05 M Tris-HCl, 0.5 M NaCl, pH 7.5). The column was washed with the same buffer to remove unbound proteins, and the bound proteins were retrieved using elution buffer (0.05 M glycine, pH 3.0) and preserved in an appropriate buffer (1 M Tris-HCl, pH 9.0). The eluted proteins were concentrated and dialyzed against buffer (10 mM Tris-HCl, pH 7.5, containing 1% CHAPS) in an Amicon Centriprep concentrator for further use.
Protein determination—Protein concentrations were determined by colorimetric assay as previously described [40], using BSA as a standard protein.
Zymographic assays—The protein fraction (15 μg) was subjected to electrophoresis under reductive conditions using 12% acrylamide gels copolymerized with 0.1% gelatin [41]. Following electrophoresis, the gels were washed (4 °C, 1 h) in 0.1 M Tris-HCl pH 7.5 containing 2.5% Triton X-100 and then incubated (37 °C, 12 h) in the same buffer. Proteinase bands were revealed by staining with Coomassie Brilliant Blue R-250. The molecular masses of the proteinase bands were calculated by comparison with the mobility of molecular mass standards (12 to 225 kDa).
Proteinase activity in solution—The proteinase activities of the serine proteinase-enriched fraction (5.0 μg total protein) were accessed in activation buffer (10 mM Tris-HCl pH 7.5), at a final volume of 60 μL using specific fluorogenic peptide substrates of serine proteinases (Z-FR-AMC and Suc-AFK-AMC at 0.1 mM). Samples were incubated (37 °C, 60 min), and the variance in the relative fluorescence was monitored with a Molecular Devices SpectraMax spectrophotometer (Gemini XPS). Additionally, inhibition assays were performed by the addition of PMSF (1 mM), aprotinin (5.0 μg) or E-64 (10 μM). The substrate cleavage rate was defined as follows: v = Δs/Δt, where v = velocity, Δs = substrate concentration variation and Δt = total reaction time [42]. The self-degradation of the fluorescent peptide substrate was controlled throughout the assay to avoid incorrect readings. The enzymatic activity is expressed as µmol min−1·mg of protein−1.
In silico analysis of subtilisin sequences—The sequences of the LbrM.13.0860 and LbrM.28.2570 subtilisins were analyzed based on their structures by using automatic servers accessed in free online platforms. Data on the secondary structures of both protein sequences were obtained by using the PredictProtein server (https://www.predictprotein.org/), [43]. The subcellular localization of proteins was assessed using the DeepLoc-1.0 server (http://www.cbs.dtu.dk/services/DeepLoc/), a eukaryotic protein subcellular localization predictor based on a hierarchical tree calculation used to predict the location of both proteins in cellular compartments. The data were generated from the percentage probability of the protein in each compartment of a eukaryotic cell [25]. The Protter server (http://wlab.ethz.ch/protter/start/) was used to visualize proteoforms [26]. The models were proposed based on the predicted protein products of both genes, according to the characteristics of their amino acid residues.
Selection of sequences and primer design—The primers were designed for this study based on the Leishmania (Viannia) braziliensis subtilisin (LbrM.13.0860: sense-5′ ATCTGGCGATTTCTCCCTTT 3′ and antisense-5′ GAGCTAACACCAG 3′; LbrM.28.2570: sense-5′ CACTGCGCTCCACATACACT 3′ and antisense-5′ GCCTTCATTCGAGCTACAGG 3′) and tryparedoxin peroxidase (LbrM.15.1080: sense-5′ CTCTGTGGACAGCGAGTACG 3′ and antisense-5′ TGGGGTCGATGATAAAGAGG 3′) sequences recorded in the Genedb database (http://www.genedb.org). The primers were designed using the online software Primer3 v. 0.4.0 (http://frodo.wi.mit.edu/primer3/), with all parameters set to default except the product size range, which was adjusted to 80–200 base pairs (bp). Additionally, primers complementary to the 40S ribosomal protein S8 gene (LbrM.24.2160: sense-5′ CGACTTGGATGCGGGGA 3′ and antisense -5′ GGCGAAGCCTTGTTCACG 3′) were used [44,45]. The primers were synthesized by Invitrogen Brazil at a concentration of 50 nM and purified by desalting.
RNA extraction and cDNA synthesis—Promastigotes in the stationary phase (107/mL) were lysed (1 mL TRIzol containing 200 μL chloroform). RNA extraction was performed using the RNeasy Mini Kit according to the manufacturer’s instructions. The sample was incubated (25 °C, 5 min) and centrifuged (10,000× g, 4 °C, 18 min). The supernatants containing RNA were mixed with ethanol (400 μL) and transferred to the column provided in the RNeasy Mini kit and then centrifuged (7200× g, 4 °C, 30 s). After that, the column was washed by centrifuged (7200× g, 4 °C, 30 s) once with RW1 buffer (700 μL) and then twice with RPE buffer (500 μL). Then, the samples were recovered in 30 μL DNAse free water (1 U/μL), and concentrations were measured by spectrophotometry at 260 nm. The RNA integrity was evaluated by 1.2% (w/v) denaturing agarose gel electrophoresis stained with Nancy-520 DNA gel stain. cDNA synthesis was performed using the SuperScript III First-Strand Synthesis System for RT-PCR (1 μg of total RNA).
Reverse Transcription Polymerase Chain Reaction (RT-PCR)—Primers complementary to the LbrM.24.2160, LbrM.13.0860, and LbrM.28.2570 genes were used for PCR under the following reaction conditions: 1 mM Tris-HCl, pH 8.3, 50 mM KCl, 4 mM MgCl2, 2.5 mM of each dNTP, 0.5 µM of each primer and 1 U Taq DNA polymerase, together with 500 ng of cDNA and adjusted to a final volume of 25 μL. The amplification cycle was performed as follows: one step (94 °C, 5 min) followed by 30 cycles (95 °C, 45 s; 60 °C, 45 s; 72 °C, 90 s) and a final elongation step (72 °C, 7 min) using a PTC-100 Thermal Cycler (Applied Biosystems, Foster City, CA, USA). The amplified products (5 µL) were evaluated by 1.2% (w/v) agarose gel electrophoresis and stained with ethidium bromide.
5. Conclusions
The results presented here bring new insight into the serine proteinases of L. (V.) braziliensis promastigotes and provide evidence of the active production of transcripts for both subtilisin (LbrM.13.0860 and LbrM.28.2570) and TXNPx (LbrM.15.1080) genes. Benzamidine used during the purification step accessed serine proteinases from the cytosol and membrane with molecular masses close to the predicted molecular masses of L. (V.) braziliensis subtilisins. Based on the structural features of their sequences, it was postulated that part of the enzymatic activity detected in the cytosolic fraction was due to the LbrM.13.0860 gene expression product, because of the predominance of hydrophilic amino acids, while the activity in the membrane fraction was partly due to the LbrM.28.2570 gene expression product, because most of its amino acids are hydrophobic. These findings suggest that promastigotes inhabiting sand flies express serine proteinases that may contribute to the maintenance of this parasite’s lifestyle at physiological pH, in the cytosol, and on the external face of the parasitic membrane.
Supplementary Materials
Supplementary materials are available online at https://www.mdpi.com/1422-0067/20/6/1315/s1.
Author Contributions
Conceptualization: C.R.A. and F.S.-S.; Data curation: L.M.d.C.C., L.C.-F. and C.R.A.; Formal analysis: Raquel Santos-de-Souza, L.C.-F. and F.S.-S.; Funding acquisition: C.R.A.; Investigation: R.S.-d.-S., K.d.S.C., L.C.-F., C.R.A. and F.S.-S.; Methodology: R.S.-d.-S., L.M.d.C.C., K.d.S.C., L.C.-F. and F.S.-S.; Project administration: C.R.A.; Resources: C.R.A.; Software: F.S.-S.; Supervision: C.R.A. and F.S.-S.; Validation: R.S.-d.-S. and K.S.C.
Funding
This study was financed in part by the Conselho Nacional de Desenvolvimento Científico e Tecnológico-Brasil (CNPq: 303569/2016-6), the Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro-Brasil (FAPERJ: E-26/010.001261/2015) and the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior-Brasil (CAPES)-Finance Code 001. Raquel S Silva and Dr. Franklin S Silva are fellows of CAPES. Carlos R. Alves is a research fellow at the CNPq institution.
Acknowledgments
We are grateful to the facilities and technical support of the Fundação Oswaldo Cruz technological platforms, the Bioassay Platform (IOC) and the Culture Medium Platform (IOC). We also thank Luiz F. G. Oliveira for your comments and suggestions.
Conflicts of Interest
The authors declare that they have no competing interests.
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
1. World Health Organization (WHO). Control of the Leishmaniasis: Report of a meeting of the World Health Organization Expert Committee on the Control of Leishmaniasis; World Health Organization: Geneva, Switzerland, 2010.
2. Akhoundi, M.; Kuhls, K.; Cannet, A.; Votýpka, J.; Marty, P.; Delaunay, P.; Sereno, D.A. Historical overview of the classification, evolution, and dispersion of leishmania parasites and sandflies. PLoS Negl. Trop. Dis. 2016, 10, e0004349.
3. Ready, P.D. Biology of phlebotomine sand flies as vectors of disease agents. Annu. Rev. Entomol. 2013, 58, 227-250.
4. Teixeira, D.E.; Benchimol, M.; Rodrigues, J.C.; Crepaldi, P.H.; Pimenta, P.F.; de Souza, W. The cell biology of Leishmania: How to teach using animations. PLoS Pathog. 2013, 9, e1003594.
5. Reithinger, R.; Dujardin, J.C.; Louzir, H.; Pirmez, C.; Alexander, B.; Brooker, S. Cutaneous Leishmaniasis. Lancet Infect. Dis. 2007, 7, 581-596.
6. Lira, R.; Rosales-Encina, J.L.; Argüello, C. Leishmania mexicana: Binding of promastigotes to type I collagen. Exp. Parasitol. 1997, 85, 149-157.
7. Alves, C.R.; Souza, R.S.; Charret, K.D.S.; Côrtes, L.M.C.; Sá-Silva, M.P.; Barral-Veloso, L.; Oliveira, L.F.G.; da Silva, F.S. Understanding serine proteases implications on Leishmania spp lifecycle. Exp. Parasitol. 2018, 184, 67-81.
8. Rawlings, N.D. Peptidase inhibitors in the MEROPS database. Biochimie 2010, 92, 1463-1483.
9. Silva-Almeida, M.; Pereira, B.A.; Ribeiro-Guimarães, M.L.; Alves, C.R. Proteinases as virulence factors in Leishmania spp. infection in mammals. Parasit Vectors 2012, 5, 160.
10. Piña-Vázquez, C.; Reyes-López, M.; Ortíz-Estrada, G.; de la Garza, M.; Serrano-Luna, J. Host-parasite interaction: Parasite-derived and -induced proteases that degrade human extracellular matrix. J. Parasitol. Res. 2012, 2012, 748206.
11. Silva-Almeida, M.; Souza-Silva, F.; Pereira, B.A.; Ribeiro-Guimarães, M.L.; Alves, C.R. Overview of the organization of protease genes in the genome of Leishmania spp. Parasit Vectors 2014, 7, 387.
12. Rawlings, N.D.; Waller, M.; Barrett, A.J.; Bateman, A. MEROPS: The database of proteolytic enzymes, their substrates and inhibitors. Nucleic Acids Res. 2014, 42, D503-D509.
13. Pereira, B.A.; Souza-Silva, F.; Silva-Almeida, M.; Santos-de-Souza, R.; Gonçalves de Oliveira, L.F.; Ribeiro-Guimarães, M.L.; Alves, C.R. Proteinase inhibitors: A promising drug class for treating leishmaniasis. Curr. Drug Targets 2014, 15, 1121-1131.
14. Wenerton, R.K.; Knudsen, G.M.; Sajid, M.; Kelly, B.L.; McKerrow, J.H. Leishmania subtilisinis a maturase for the trypanothione reductase system and contributes to disease pathology. J. Biol. Chem. 2010, 285, 31120-31129.
15. Nocua, P.A.; Ramirez, C.A.; Requena, J.M.; Puerta, C.J. Leishmania braziliensis SCD6 and RBP42 proteins, two factors with RNA binding capacity. Parasit Vectors 2017, 10, 610.
16. Diaz, J.R.; Ramírez, C.A.; Nocua, P.A.; Guzman, F.; Requena, J.M.; Puerta, C.J. Dipeptidyl peptidase 3, a novel protease from Leishmania braziliensis. PLoS ONE 2018, 13, e0190618.
17. Gontijo, B.; Carvalho, M.L.R. Leishmaniose tegumentar americana. Rev. Soc. Bras. Med. Trop. 2003, 36, 71-80.
18. Cortesio, C.L.; Jiang, W. Mannan-binding lectin-associated serine protease 3 cleaves synthetic peptides and insulin-like growth factor-binding protein 5. Arch. Biochem. Biophys. 2006, 449, 164-170.
19. Miura, Y.; Kawabata, S.; Wakamiya, Y.; Nakamura, T.; Iwanaga, S. A limulus intracellular coagulation inhibitor type 2. Purification, characterization, cDNA cloning, and tissue localization. J. Biol. Chem. 1995, 270, 558-565.
20. Alves, C.R.; Marzochi, M.C.; Giovanni-de-Simone, S. Heterogeneity of cysteine proteinases in Leishmania braziliensis and Leishmania major. Braz. J. Med. Biol. Res. 1993, 26, 167-171.
21. Guedes, H.L.; Rezende, J.M.; Fonseca, M.A.; Salles, C.M.; Rossi-Bergmann, B.; De-Simone, S.G. Identification of serine proteases from Leishmania braziliensis. Z. Naturforsch. C 2007, 62, 373-381.
22. Ottesen, M.; Svendsen, I. The subtilisins. Methods Enzymol. 1970, 19, 199-215.
23. Markland, F.S.; Smith, E.L. Subtilisins: Primary structure, chemical and physical properties. In The Enzymes, 3rd ed.; Boyer, P.D., Ed.; Academic Press: New York, NY, USA, 1971; pp. 561-608.
24. Philipp, M.; Bender, M.L. Kinetics of subtilisin and thiolsubtilisin. Mol. Cell. Biochem. 1983, 51, 5-32.
25. Almagro Armenteros, J.J.; Sønderby, C.K.; Sønderby, S.K.; Nielsen, H.; Winther, O. DeepLoc: Prediction of protein subcellular localization using deep learning. Bioinformatics 2017, 33, 3387-3395.
26. Omasits, U.; Ahrens, C.H.; Müller, S.; Wollscheid, B. Protter: Interactive protein feature visualization and integration with experimental proteomic data. Bioinformatics 2014, 30, 884-886.
27. Ikemura, H.; Takagi, H.; Inouye, M. Requirement of pro-sequence for the production of active subtilisin E in Escherichia coli. J. Biol. Chem. 1987, 262, 7859-7864.
28. Nedkov, P.; Oberthür, W.; Braunitzer, G. Determination of the complete amino-acid sequence of subtilisin DY and its comparison with the primary structures of the subtilisins BPN', Carlsberg and amylosacchariticus. Biol. Chem. 1985, 366, 421-430.
29. Paetzel, M.; Dalbey, R.E.; Strynadka, N.C.J. Crystal structure of a bacterial signal peptidase apoenzyme: Implications for signal peptide binding and the Ser-Lys dyad mechanism. Nature 1998, 396, 186-190.
30. Iyer, J.P.; Kaprakkaden, A.; Choudhary, M.L.; Shaha, C. Crucial role of cytosolic tryparedoxin peroxidase in Leishmania donovani survival, drug response and virulence. Mol. Microbiol. 2008, 68, 372-391.
31. Lin, Y.C.; Hsu, J.Y.; Chiang, S.C.; Lee, S.T. Distinct overexpression of cytosolic and mitochondrial tryparedoxin peroxidases results in preferential detoxification of different oxidants in arsenite-resistant Leishmania amazonensis with and without DNA amplification. Mol. Biochem. Parasitol. 2005, 142, 66-75.
32. Castro, H.; Sousa, C.; Santos, M.; Cordeiro-da-Silva, A.; Flohé, L.; Tomás, A.M. Complementary antioxidant defense by cytoplasmic and mitochondrial peroxiredoxins in Leishmania infantum. Free Radic. Biol. Med. 2002, 33, 1552-1562.
33. De Morais, M.A.; de Souza, T.A.; Murakami, M.T. Cloning, expression, purification, crystallization and preliminary X-ray diffraction analysis of the mitochondrial tryparedoxin peroxidase from Leishmania braziliensis. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 2013, 69, 408-411.
34. Alcolea, P.J.; Alonso, A.; García-Tabares, F.; Mena, M.C.; Ciordia, S.; Larraga, V. Increased abundance of proteins involved in resistance to oxidative and nitrosative stress at the last stages of growth and development of Leishmania amazonensis promastigotes revealed by proteome analysis. PLoS ONE 2016, 11, e0164344.
35. Barrett, A.J.; Kembhavi, A.A.; Brown, M.A.; Kirschke, H.; Knight, C.G.; Tamai, M.; Hanada, K. L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L. Biochem. J. 1982, 201, 189-198. [Green Version]
36. Sonia, V.; Rajnikant, D.; Kailash, C. Cysteine Proteases: Modes of Activation and Future Prospects as Pharmacological Targets. Pandey Front. Pharmacol. 2016, 7, 107.
37. Andreeva, N.; Bogdanovich, P.; Kashparov, I.; Popov, M.; Stengach, M. Is Histoaspartic protease a serine protease with a pepsin-like fold? Proteins 2004, 55, 705-710.
38. Morgado-Diaz, J.A.; Silva-Lopez, R.E.; Alves, C.R.; Soares, M.J.; Corte-Real, S.; Giovanni-De-Simoni, S. Subcellular localization of an intracellular serine protease of 68 kDa in Leishmania (Leishmania) amazonensis promastigotes. Mem Ins Oswaldo Cruz. 2005, 100, 377-383.
39. De Castro Côrtes, L.M.; Pereira, M.C.S.; Oliveira, F.O., Jr.; Corte-Real, S.; Silva, F.S.; Pereira, B.A.; Fátima Madeira, M.; Moraes, M.T.; Brazil, R.P.; Alves, C.R. Leishmania (Viannia) braziliensis: Insights on subcellular distribution and biochemical properties of heparin-binding proteins. Parasitology 2012, 139, 200-207.
40. Lowry, O.H.; Rosebrough, N.J.; Farr, A.L.; Randall, R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193, 265-275.
41. Heussen, C.; Dowdle, E.B. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal. Biochem. 1980, 102, 196-202.
42. Alves, C.R.; Corte-Real, S.; Bourguignon, S.C.; Chaves, C.S.; Saraiva, E.M. Leishmania amazonensis: Early proteinase activities during promastigote-amastigote differentiation in vitro. Exp. Parasitol. 2005, 109, 38-48.
43. Yachdav, G.; Kloppmann, E.; Kajan, L.; Hecht, M.; Goldberg, T.; Hamp, T.; Hönigschmid, P.; Schafferhans, A.; Roos, M.; Bernhofer, M.; et al. PredictProtein an open resource for online prediction of protein structural and functional features. Nucleic Acids Res. 2014, 42, W337-W343.
44. Adaui, V.; Schnorbusch, K.; Zimic, M.; Gutiérrez, A.; Decuypere, S.; Vanaerschot, M.; DEDoncker, S.; Maes, I.; Llanos-Cuentas, A.; Chappuis, F.; et al. Comparison of gene expression patterns among Leishmania braziliensis clinical isolates showing a different in vitro susceptibility to pentavalent antimony. Parasitology 2011, 138, 183-193.
45. Cysne-Finkelstein, L.; Silva-Almeida, M.; Pereira, B.A.S.; Charret, K.S.; Bertho, Á.L.; Bastos, L.S.; de Oliveira Pinto, L.; de Oliveira, F.O.R.; Pereira, M.C.S.; Alves, C.R. Evidence of Subpopulations with Distinct Biological Features Within a Leishmania (Viannia) braziliensis Strain. Protist 2018, 69, 107-121.
1Fundação Oswaldo Cruz, Instituto Oswaldo Cruz, Laboratório de Biologia Molecular e Doenças Endêmicas, Avenida Brasil, 4365, Manguinhos, Rio de Janeiro 21040-900, Brazil
2Fundação Oswaldo Cruz, Instituto Oswaldo Cruz, Laboratório de Imunoparasitologia, Avenida Brasil, 4365, Manguinhos, Rio de Janeiro 21040-900, Brazil
3Fundação Oswaldo Cruz, Centro de Desenvolvimento Tecnológico em Saúde, Avenida Brasil, 4365, Manguinhos, Rio de Janeiro 21040-900, Brazil
*Author to whom correspondence should be addressed.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2019. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Abstract
Based on the method of peptide bond cleavage, there are two groups of serine proteinases: exopeptidases (EC 3.4.11-19) that cleave peptide bonds at the ends of a polypeptide, and endopeptidases or proteinases (EC 3.4.21-99), which cleave internal peptide bonds within the polypeptide chain and are named based on the amino acids that form the catalytic site, e.g., aspartic proteinases, cysteine proteinases, metalloproteinases, serine proteinases, threonine proteinases, and glutamic proteinases [8]. Aspartic proteinases, cysteine proteinases, metalloproteinases, and serine proteinases whose actions ensure the survival, proliferation, and maintenance of the Leishmania spp. life cycle in the host have been described. [...]only the genes LinJ13_V3.0940 and LmjF13.1040 have been related with this function [14]. Since these genes are orthologous to serine proteinases in L.(V.) braziliensis, it is possible that the Lbrm.13.0860 gene has the same function, but this has not yet been confirmed for the gene in chromosome 28. Both the membrane and cytosolic fractions were obtained from 108 promastigotes/mL yielding approximately 0.6 ± 0.02 mg/mL protein, which showed a gelatin-SDS-PAGE profile with major proteinase bands with estimated molecular masses of 43 kDa, 48 kDa, 63 kDa, 99 kDa, and 170 kDa in the cytosolic fraction and 67 kDa, 75 kDa, and 170 kDa in the membrane fraction (Figure 1 inset).
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer